Abstract
Sexual dysfunctions, including but not limited to erectile dysfunction, are common in the aging male, particularly in the setting of diabetes. After reviewing some of the general issues that may lead to sexual dysfunction in the elderly, this review focuses on clinically relevant studies that have been conducted in diabetic men. Specifically, the review addresses the role of phosphodiesterase type 5 inhibitors, intracavernosal injections, vacuum devices and penile prosthesis in the diabetic population, as well as discussing ejaculatory problems.
Acknowledgements
A Bella is the American Urologic Association Foundation Robert J Krane Scholar and a Royal College of Physicians and Surgeons (Canada) Detweiler Traveling Fellow.
Disclosures
Bayer-GSK: Consultant/Advisor; Genix: Board Member/Officer/Trustee; Lilly ICOS: Consultant/Advisor; NexMed: Consultant/Advisor; Pfizer: Consultant/Advisor; TAP: Investigator; Astellas: Investigator; Rinat: Investigator; Biopharm: Investigator.